Clinical Trial Update: Efficacy of Sildenafil on the Morbi-mortality of Peripheral Arterial Diseased Patients With Intermittent Claudication [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sildenafil for peripheral arterial disease with intermittent claudication was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University Hospital, Angers | Conditions: Peripheral Arterial Occlusive Disease | Phase 3 | Status: WITHDRAWN